Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janusz Rak

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Signal Transduction and Targeted Therapy|May 23, 2026
An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastomaAmir Hossein Mansourabadi, Dianbo Qu, Francesca Cianci, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastomaAmir Hossein Mansourabadi, Dianbo Qu, Francesca Cianci, et al.
The Journal of Pathology|June 20, 2020
SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumorsYibo Xue, Xianbing Zhu, Brian Meehan, et al.
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Blood Advances|March 15, 2021
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesiclesNadim Tawil, Rayhaan Bassawon, Brian Meehan, et al.
Nature Communications|September 14, 2021
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondriaYibo Xue, Jordan L Morris, Kangning Yang, et al.
Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.
Nature Communications|February 6, 2019
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovaryYibo Xue, Brian Meehan, Elizabeth Macdonald, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Nature|April 17, 2020
A reference map of the human binary protein interactomeKatja Luck, Dae-Kyum Kim, Luke Lambourne, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Signal Transduction and Targeted Therapy|May 23, 2026
An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastomaAmir Hossein Mansourabadi, Dianbo Qu, Francesca Cianci, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastomaAmir Hossein Mansourabadi, Dianbo Qu, Francesca Cianci, et al.
The Journal of Pathology|June 20, 2020
SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumorsYibo Xue, Xianbing Zhu, Brian Meehan, et al.
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Blood Advances|March 15, 2021
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesiclesNadim Tawil, Rayhaan Bassawon, Brian Meehan, et al.
Nature Communications|September 14, 2021
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondriaYibo Xue, Jordan L Morris, Kangning Yang, et al.
Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.
Nature Communications|February 6, 2019
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovaryYibo Xue, Brian Meehan, Elizabeth Macdonald, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Nature|April 17, 2020
A reference map of the human binary protein interactomeKatja Luck, Dae-Kyum Kim, Luke Lambourne, et al.
Pageof 24